Biostem

Biostem

Created using Figma
Created using Figma
Tecnologia cellulare biochimica altamente sofisticata combinata con tecnologia blockchain. Biostem è una tecnologia all'avanguardia che mira a rivoluzionare il settore medico e biotecnologico moderno fornendo una piattaforma decentralizzata che può essere utilizzata per attività transazionali, finalità di monitoraggio, produzione e outsourcing del contratto, monitoraggio e registrazione dei dati dei pazienti, ottimizzazione dei cicli di vita dei dispositivi medici e assistenza sanitaria , produzione di contratti e gestione di prove cliniche. In tal modo, miriamo anche a garantire che i moderni prodotti Biotech siano prontamente disponibili per tutti, non solo per i ricchi, a tariffe più economiche.
PRE SALE
1 apr 2019
30 mag 2019
100% completato
Fondi raccolti - nessun dato
past
Dettagli del token
Distribuzione di token
ICO Crowdfunding 30%
Founder Team 15%
Angel Funding 45%
Publisher 10%
Valute accettate
ETH
Dettagli della Compagnia
Paese registrato
Malaysia
dettagli aggiuntivi
categorie
piattaforma, tecnologia

Di Biostem

MYK was established as a biotechnology manufacturer and Biotech Research Laboratory aiming to contribute to the world health and medical industry through globalizing biotechnology. Its main business areas are: health and medical industry, finance and industrial investment, and sophisticated technologies such as blockchain and Biotechnology. MYK regards technology as the core and quality as its life, and wholeheartedly builds the company into a world-class branded enterprise. Comprised of a world-class medical team and cutting-edge biotechnology equipment, MYK provides a global scaled advanced medical technology and research service platform. It provides world-class screening, diagnosis, treatment and rehabilitation services for oncological diseases; has built patient-centered, unique health management system; provide community-based prevention, diagnosis, treatment, rehabilitation, and health services, while also providing medical services. In addition, anti-aging services are supplemented to create a brand-new living experience; in response to the needs of an aging population and the improvement of the quality of life of residents, the company has created the “MYK Cell Bank” as an important carrier for healthy living and provides high-end international medical care. Health management, health care services and other age-based health care services should provide strength for the common people to achieve physical and mental health and a better life.

Biostem is a project by MYK aiming to revolutionize the traditional Medical and Biotechnology industry by providing a decentralized blockchain for storing patient, clinical and research record, and smart contracts like features for trustless outsourcing of Biotech contracts.

Our Mission

Biostem aims to contribute to the world health and medical industry by creating an ecosystem that would make the Patient’s Clinical Record and the Biotech Contract Outsourcing process, distributed through a decentralized blockchain, so that, anyone can have access to high end, state of the art medical diagnosis, treatment and Biotech products at ease.

Biostem

Biostem is state of the art ERC-20 Virtual Currency that allows peer to peer mode of payment and is deployed on decentralized ethereum blockchain based technology. The currency would be used for funding the research work, daily transactional activities happening within the Biostem health and financial ecosystem, for health care services and can also be used as a peer to peer exchange and store of value between users: securely, efficiently at reduced costs. Biostem will utilize ethereum blockchain technology to enhance its services to patients, hospitals, research centers and daily consumers, sellers, and merchants. This allows a level of transparency that was previously unrealized, while incentivizing users to adopt and use the platform. This will be done through the creation and use of Biostems.

Attività

Seguaci:
21
VERY LOW
tweets:
50
LOW
Crescita di 30 giorni:

Biostem Squadra

verificata 0%

Attenzione. C'è il rischio che i membri non verificati non siano effettivamente membri del team

Dr. Rubern
Chief Executive Officer
non verificato
Dawson Roland
Chief Technology Officer
non verificato
Kelson Beck
Chief Marketing Officer
non verificato
Matthew Hudson
Chief Financial Officer
non verificato
Catherine Harrison
Chief Operating Officer
non verificato
Rina
Biotech Consultant
non verificato
Allyson Brock
Human Resource Director
non verificato
Jozie Ayaz Khan
Business Development Director
non verificato
Brayden Parker
Biotech Research Consultant
non verificato
Sanjay Uttam Kharade
Business Consultant - Asia
non verificato

Biostem Ultime novità

N/A
5.0 10
ICO Profilo Visione Attività Potenziale Prodotto Squadra
  • Poiché potrebbero esserci differenze temporali negli aggiornamenti delle informazioni, è necessario verificare le informazioni accurate su ciascun progetto ICO attraverso il suo sito web ufficiale o altri canali di comunicazione.
  • Questa informazione non è un suggerimento o consiglio su come investire in finanziamenti ICO. Si prega di indagare approfonditamente le informazioni rilevanti da soli e decidere sulla partecipazione ICO.
  • Se pensi che ci siano problemi o problemi da correggere su questo contenuto, o se desideri inviare il tuo progetto ICO da elencare, per favore inviaci un'email.
Si prega di leggere la dichiarazione di non responsabilità e l'avviso di rischio. Mostra disclaimer e avviso di rischio.
Planning an ICO? We can help with a wide range of support for all stages of your ICO